Global CGT CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global CGT CDMO market size was valued at USD 4062.1 million in 2022 and is forecast to a readjusted size of USD 17320 million by 2029 with a CAGR of 23.0% during review period.

CGT CDMO is a contract service provider specializing in cell and gene therapy development and manufacturing. These organizations focus on supporting product development in the field of cell and gene therapies by pharmaceutical companies, biotechnology companies and research institutions.

Global key players of CGT CDMO include Catalent, Lonza and Thermo Fisher, etc. The top three players hold a share over 60%. North America is the largest market, has a share about 50%. In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.

The Global Info Research report includes an overview of the development of the CGT CDMO industry chain, the market status of Pharmaceutical and Biotechnology Companies (Immune Cells, Stem Cells), Research and Academic Institutions (Immune Cells, Stem Cells), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CGT CDMO.

Regionally, the report analyzes the CGT CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CGT CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the CGT CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CGT CDMO industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immune Cells, Stem Cells).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CGT CDMO market.

Regional Analysis: The report involves examining the CGT CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CGT CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to CGT CDMO:
Company Analysis: Report covers individual CGT CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CGT CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical and Biotechnology Companies, Research and Academic Institutions).

Technology Analysis: Report covers specific technologies relevant to CGT CDMO. It assesses the current state, advancements, and potential future developments in CGT CDMO areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CGT CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
CGT CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Immune Cells
    Stem Cells
    Viral Vectors
    Plasmid DNA

Market segment by Application
    Pharmaceutical and Biotechnology Companies
    Research and Academic Institutions
    Hospital
    Others

Market segment by players, this report covers
    Catalent
    Lonza
    Thermo Fisher
    ACG Biologics
    WuXi AppTec
    Charles River
    Oxford Biomedica (OXB)
    Novartis
    OBiO
    GenScript
    Pharmaron
    Porton

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CGT CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CGT CDMO, with revenue, gross margin and global market share of CGT CDMO from 2018 to 2023.
Chapter 3, the CGT CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CGT CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CGT CDMO.
Chapter 13, to describe CGT CDMO research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of CGT CDMO
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of CGT CDMO by Type
        1.3.1 Overview: Global CGT CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global CGT CDMO Consumption Value Market Share by Type in 2022
        1.3.3 Immune Cells
        1.3.4 Stem Cells
        1.3.5 Viral Vectors
        1.3.6 Plasmid DNA
    1.4 Global CGT CDMO Market by Application
        1.4.1 Overview: Global CGT CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical and Biotechnology Companies
        1.4.3 Research and Academic Institutions
        1.4.4 Hospital
        1.4.5 Others
    1.5 Global CGT CDMO Market Size & Forecast
    1.6 Global CGT CDMO Market Size and Forecast by Region
        1.6.1 Global CGT CDMO Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global CGT CDMO Market Size by Region, (2018-2029)
        1.6.3 North America CGT CDMO Market Size and Prospect (2018-2029)
        1.6.4 Europe CGT CDMO Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific CGT CDMO Market Size and Prospect (2018-2029)
        1.6.6 South America CGT CDMO Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa CGT CDMO Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Catalent
        2.1.1 Catalent Details
        2.1.2 Catalent Major Business
        2.1.3 Catalent CGT CDMO Product and Solutions
        2.1.4 Catalent CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Catalent Recent Developments and Future Plans
    2.2 Lonza
        2.2.1 Lonza Details
        2.2.2 Lonza Major Business
        2.2.3 Lonza CGT CDMO Product and Solutions
        2.2.4 Lonza CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Lonza Recent Developments and Future Plans
    2.3 Thermo Fisher
        2.3.1 Thermo Fisher Details
        2.3.2 Thermo Fisher Major Business
        2.3.3 Thermo Fisher CGT CDMO Product and Solutions
        2.3.4 Thermo Fisher CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Thermo Fisher Recent Developments and Future Plans
    2.4 ACG Biologics
        2.4.1 ACG Biologics Details
        2.4.2 ACG Biologics Major Business
        2.4.3 ACG Biologics CGT CDMO Product and Solutions
        2.4.4 ACG Biologics CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 ACG Biologics Recent Developments and Future Plans
    2.5 WuXi AppTec
        2.5.1 WuXi AppTec Details
        2.5.2 WuXi AppTec Major Business
        2.5.3 WuXi AppTec CGT CDMO Product and Solutions
        2.5.4 WuXi AppTec CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 WuXi AppTec Recent Developments and Future Plans
    2.6 Charles River
        2.6.1 Charles River Details
        2.6.2 Charles River Major Business
        2.6.3 Charles River CGT CDMO Product and Solutions
        2.6.4 Charles River CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Charles River Recent Developments and Future Plans
    2.7 Oxford Biomedica (OXB)
        2.7.1 Oxford Biomedica (OXB) Details
        2.7.2 Oxford Biomedica (OXB) Major Business
        2.7.3 Oxford Biomedica (OXB) CGT CDMO Product and Solutions
        2.7.4 Oxford Biomedica (OXB) CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Oxford Biomedica (OXB) Recent Developments and Future Plans
    2.8 Novartis
        2.8.1 Novartis Details
        2.8.2 Novartis Major Business
        2.8.3 Novartis CGT CDMO Product and Solutions
        2.8.4 Novartis CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Novartis Recent Developments and Future Plans
    2.9 OBiO
        2.9.1 OBiO Details
        2.9.2 OBiO Major Business
        2.9.3 OBiO CGT CDMO Product and Solutions
        2.9.4 OBiO CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 OBiO Recent Developments and Future Plans
    2.10 GenScript
        2.10.1 GenScript Details
        2.10.2 GenScript Major Business
        2.10.3 GenScript CGT CDMO Product and Solutions
        2.10.4 GenScript CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 GenScript Recent Developments and Future Plans
    2.11 Pharmaron
        2.11.1 Pharmaron Details
        2.11.2 Pharmaron Major Business
        2.11.3 Pharmaron CGT CDMO Product and Solutions
        2.11.4 Pharmaron CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Pharmaron Recent Developments and Future Plans
    2.12 Porton
        2.12.1 Porton Details
        2.12.2 Porton Major Business
        2.12.3 Porton CGT CDMO Product and Solutions
        2.12.4 Porton CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Porton Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global CGT CDMO Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of CGT CDMO by Company Revenue
        3.2.2 Top 3 CGT CDMO Players Market Share in 2022
        3.2.3 Top 6 CGT CDMO Players Market Share in 2022
    3.3 CGT CDMO Market: Overall Company Footprint Analysis
        3.3.1 CGT CDMO Market: Region Footprint
        3.3.2 CGT CDMO Market: Company Product Type Footprint
        3.3.3 CGT CDMO Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global CGT CDMO Consumption Value and Market Share by Type (2018-2023)
    4.2 Global CGT CDMO Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global CGT CDMO Consumption Value Market Share by Application (2018-2023)
    5.2 Global CGT CDMO Market Forecast by Application (2024-2029)

6 North America
    6.1 North America CGT CDMO Consumption Value by Type (2018-2029)
    6.2 North America CGT CDMO Consumption Value by Application (2018-2029)
    6.3 North America CGT CDMO Market Size by Country
        6.3.1 North America CGT CDMO Consumption Value by Country (2018-2029)
        6.3.2 United States CGT CDMO Market Size and Forecast (2018-2029)
        6.3.3 Canada CGT CDMO Market Size and Forecast (2018-2029)
        6.3.4 Mexico CGT CDMO Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe CGT CDMO Consumption Value by Type (2018-2029)
    7.2 Europe CGT CDMO Consumption Value by Application (2018-2029)
    7.3 Europe CGT CDMO Market Size by Country
        7.3.1 Europe CGT CDMO Consumption Value by Country (2018-2029)
        7.3.2 Germany CGT CDMO Market Size and Forecast (2018-2029)
        7.3.3 France CGT CDMO Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom CGT CDMO Market Size and Forecast (2018-2029)
        7.3.5 Russia CGT CDMO Market Size and Forecast (2018-2029)
        7.3.6 Italy CGT CDMO Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific CGT CDMO Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific CGT CDMO Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific CGT CDMO Market Size by Region
        8.3.1 Asia-Pacific CGT CDMO Consumption Value by Region (2018-2029)
        8.3.2 China CGT CDMO Market Size and Forecast (2018-2029)
        8.3.3 Japan CGT CDMO Market Size and Forecast (2018-2029)
        8.3.4 South Korea CGT CDMO Market Size and Forecast (2018-2029)
        8.3.5 India CGT CDMO Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia CGT CDMO Market Size and Forecast (2018-2029)
        8.3.7 Australia CGT CDMO Market Size and Forecast (2018-2029)

9 South America
    9.1 South America CGT CDMO Consumption Value by Type (2018-2029)
    9.2 South America CGT CDMO Consumption Value by Application (2018-2029)
    9.3 South America CGT CDMO Market Size by Country
        9.3.1 South America CGT CDMO Consumption Value by Country (2018-2029)
        9.3.2 Brazil CGT CDMO Market Size and Forecast (2018-2029)
        9.3.3 Argentina CGT CDMO Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa CGT CDMO Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa CGT CDMO Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa CGT CDMO Market Size by Country
        10.3.1 Middle East & Africa CGT CDMO Consumption Value by Country (2018-2029)
        10.3.2 Turkey CGT CDMO Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia CGT CDMO Market Size and Forecast (2018-2029)
        10.3.4 UAE CGT CDMO Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 CGT CDMO Market Drivers
    11.2 CGT CDMO Market Restraints
    11.3 CGT CDMO Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 CGT CDMO Industry Chain
    12.2 CGT CDMO Upstream Analysis
    12.3 CGT CDMO Midstream Analysis
    12.4 CGT CDMO Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global CGT CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global CGT CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global CGT CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global CGT CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Catalent Company Information, Head Office, and Major Competitors
    Table 6. Catalent Major Business
    Table 7. Catalent CGT CDMO Product and Solutions
    Table 8. Catalent CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Catalent Recent Developments and Future Plans
    Table 10. Lonza Company Information, Head Office, and Major Competitors
    Table 11. Lonza Major Business
    Table 12. Lonza CGT CDMO Product and Solutions
    Table 13. Lonza CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Lonza Recent Developments and Future Plans
    Table 15. Thermo Fisher Company Information, Head Office, and Major Competitors
    Table 16. Thermo Fisher Major Business
    Table 17. Thermo Fisher CGT CDMO Product and Solutions
    Table 18. Thermo Fisher CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Thermo Fisher Recent Developments and Future Plans
    Table 20. ACG Biologics Company Information, Head Office, and Major Competitors
    Table 21. ACG Biologics Major Business
    Table 22. ACG Biologics CGT CDMO Product and Solutions
    Table 23. ACG Biologics CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. ACG Biologics Recent Developments and Future Plans
    Table 25. WuXi AppTec Company Information, Head Office, and Major Competitors
    Table 26. WuXi AppTec Major Business
    Table 27. WuXi AppTec CGT CDMO Product and Solutions
    Table 28. WuXi AppTec CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. WuXi AppTec Recent Developments and Future Plans
    Table 30. Charles River Company Information, Head Office, and Major Competitors
    Table 31. Charles River Major Business
    Table 32. Charles River CGT CDMO Product and Solutions
    Table 33. Charles River CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Charles River Recent Developments and Future Plans
    Table 35. Oxford Biomedica (OXB) Company Information, Head Office, and Major Competitors
    Table 36. Oxford Biomedica (OXB) Major Business
    Table 37. Oxford Biomedica (OXB) CGT CDMO Product and Solutions
    Table 38. Oxford Biomedica (OXB) CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Oxford Biomedica (OXB) Recent Developments and Future Plans
    Table 40. Novartis Company Information, Head Office, and Major Competitors
    Table 41. Novartis Major Business
    Table 42. Novartis CGT CDMO Product and Solutions
    Table 43. Novartis CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Novartis Recent Developments and Future Plans
    Table 45. OBiO Company Information, Head Office, and Major Competitors
    Table 46. OBiO Major Business
    Table 47. OBiO CGT CDMO Product and Solutions
    Table 48. OBiO CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. OBiO Recent Developments and Future Plans
    Table 50. GenScript Company Information, Head Office, and Major Competitors
    Table 51. GenScript Major Business
    Table 52. GenScript CGT CDMO Product and Solutions
    Table 53. GenScript CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. GenScript Recent Developments and Future Plans
    Table 55. Pharmaron Company Information, Head Office, and Major Competitors
    Table 56. Pharmaron Major Business
    Table 57. Pharmaron CGT CDMO Product and Solutions
    Table 58. Pharmaron CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Pharmaron Recent Developments and Future Plans
    Table 60. Porton Company Information, Head Office, and Major Competitors
    Table 61. Porton Major Business
    Table 62. Porton CGT CDMO Product and Solutions
    Table 63. Porton CGT CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Porton Recent Developments and Future Plans
    Table 65. Global CGT CDMO Revenue (USD Million) by Players (2018-2023)
    Table 66. Global CGT CDMO Revenue Share by Players (2018-2023)
    Table 67. Breakdown of CGT CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 68. Market Position of Players in CGT CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 69. Head Office of Key CGT CDMO Players
    Table 70. CGT CDMO Market: Company Product Type Footprint
    Table 71. CGT CDMO Market: Company Product Application Footprint
    Table 72. CGT CDMO New Market Entrants and Barriers to Market Entry
    Table 73. CGT CDMO Mergers, Acquisition, Agreements, and Collaborations
    Table 74. Global CGT CDMO Consumption Value (USD Million) by Type (2018-2023)
    Table 75. Global CGT CDMO Consumption Value Share by Type (2018-2023)
    Table 76. Global CGT CDMO Consumption Value Forecast by Type (2024-2029)
    Table 77. Global CGT CDMO Consumption Value by Application (2018-2023)
    Table 78. Global CGT CDMO Consumption Value Forecast by Application (2024-2029)
    Table 79. North America CGT CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 80. North America CGT CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 81. North America CGT CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. North America CGT CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. North America CGT CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 84. North America CGT CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 85. Europe CGT CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 86. Europe CGT CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 87. Europe CGT CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 88. Europe CGT CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 89. Europe CGT CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 90. Europe CGT CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 91. Asia-Pacific CGT CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 92. Asia-Pacific CGT CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 93. Asia-Pacific CGT CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 94. Asia-Pacific CGT CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 95. Asia-Pacific CGT CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 96. Asia-Pacific CGT CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 97. South America CGT CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 98. South America CGT CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 99. South America CGT CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 100. South America CGT CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 101. South America CGT CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 102. South America CGT CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 103. Middle East & Africa CGT CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 104. Middle East & Africa CGT CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 105. Middle East & Africa CGT CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 106. Middle East & Africa CGT CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 107. Middle East & Africa CGT CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 108. Middle East & Africa CGT CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 109. CGT CDMO Raw Material
    Table 110. Key Suppliers of CGT CDMO Raw Materials
List of Figures
    Figure 1. CGT CDMO Picture
    Figure 2. Global CGT CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global CGT CDMO Consumption Value Market Share by Type in 2022
    Figure 4. Immune Cells
    Figure 5. Stem Cells
    Figure 6. Viral Vectors
    Figure 7. Plasmid DNA
    Figure 8. Global CGT CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. CGT CDMO Consumption Value Market Share by Application in 2022
    Figure 10. Pharmaceutical and Biotechnology Companies Picture
    Figure 11. Research and Academic Institutions Picture
    Figure 12. Hospital Picture
    Figure 13. Others Picture
    Figure 14. Global CGT CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global CGT CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market CGT CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global CGT CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global CGT CDMO Consumption Value Market Share by Region in 2022
    Figure 19. North America CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global CGT CDMO Revenue Share by Players in 2022
    Figure 25. CGT CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players CGT CDMO Market Share in 2022
    Figure 27. Global Top 6 Players CGT CDMO Market Share in 2022
    Figure 28. Global CGT CDMO Consumption Value Share by Type (2018-2023)
    Figure 29. Global CGT CDMO Market Share Forecast by Type (2024-2029)
    Figure 30. Global CGT CDMO Consumption Value Share by Application (2018-2023)
    Figure 31. Global CGT CDMO Market Share Forecast by Application (2024-2029)
    Figure 32. North America CGT CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America CGT CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America CGT CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe CGT CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe CGT CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe CGT CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 42. France CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific CGT CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific CGT CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific CGT CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 49. China CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 52. India CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America CGT CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America CGT CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America CGT CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa CGT CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa CGT CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa CGT CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 66. CGT CDMO Market Drivers
    Figure 67. CGT CDMO Market Restraints
    Figure 68. CGT CDMO Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of CGT CDMO in 2022
    Figure 71. Manufacturing Process Analysis of CGT CDMO
    Figure 72. CGT CDMO Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Catalent
Lonza
Thermo Fisher
ACG Biologics
WuXi AppTec
Charles River
Oxford Biomedica (OXB)
Novartis
OBiO
GenScript
Pharmaron
Porton